Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979199114> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W2979199114 endingPage "S111" @default.
- W2979199114 startingPage "S110" @default.
- W2979199114 abstract "Purpose: Telaprevir, a Hepatitis C Virus (HCV) NS3/4A protease inhibitor, is a substrate and inhibitor of cytochrome P-450 3A (CYP3A) and a substrate and inhibitor of P-glycoprotein (P-gp). A number of studies were conducted to examine the clinical significance of drug interactions between telaprevir and other medications. Methods: Multiple clinical studies were conducted in healthy volunteers to determine the drug interaction potential of telaprevir with substrates, inhibitors, and inducers of CYP3A as well as digoxin, a substrate of P-gp. Results: Drugs that had substantially increased exposure (AUC) when coadministered with telaprevir included atorvastatin (8-fold), cyclosporine (4.6-fold), oral midazolam (9-fold), and tacrolimus (70-fold). Other notable interactions included a significant reduction in the exposure of the ethinyl estradiol (28%) component of oral contraceptives and in the exposures of ritonavir-boosted HIV protease inhibitors, darunavir (40%) and fosamprenavir (47%), when telaprevir was co-administered. Rifampin, an inducer of CYP3A, caused a substantial (92%) reduction in telaprevir exposure. Telaprevir exposure was also reduced significantly by efavirenz (26%) and by ritonavir-boosted HIV protease inhibitors, lopinavir (54%), darunavir (35%), and fosamprenavir (32%). Other drugs that had increased exposures in the presence of telaprevir were alprazolam (1.35-fold), amlodipine (2.8-fold), digoxin (1.85-fold), i.v. midazolam (3.4-fold), and tenofovir (1.1 to 1.3-fold); drugs that had lowered exposure in the presence of telaprevir were escitalopram (35%), zolpidem (47%) and R-methadone (29%). For methadone, while the total levels of R-methadone in the plasma were reduced in the presence of telaprevir, the protein-unbound levels were similar before and after co-administration of telaprevir, suggesting a lack of clinically significant interaction based on protein-binding displacement. Conclusion: The interaction profile of telaprevir was similar to that of protease inhibitors for HIV and has been well characterized in drug interaction studies with a broad range of commonly used drugs. Based on the degree of interaction and the clinical consequences, certain drugs are contraindicated with telaprevir and several others require dose modification and/or monitoring for adverse events. Health practitioners should consult the full prescribing information prior to and during treatment for potential drug interactions. Disclosure: Drs. Garg and Kauffman are employees and stock holders of Vertex Pharmaceuticals Incorporated Drs. Beumont and van Heeswijk are employees and stock holders of Tibotec BVBA." @default.
- W2979199114 created "2019-10-10" @default.
- W2979199114 creator A5011659892 @default.
- W2979199114 creator A5025261212 @default.
- W2979199114 creator A5066575140 @default.
- W2979199114 creator A5086844845 @default.
- W2979199114 date "2011-10-01" @default.
- W2979199114 modified "2023-09-23" @default.
- W2979199114 title "Drug Interaction Profile of Telaprevir: 2011 ACG Presidential Poster" @default.
- W2979199114 doi "https://doi.org/10.14309/00000434-201110002-00281" @default.
- W2979199114 hasPublicationYear "2011" @default.
- W2979199114 type Work @default.
- W2979199114 sameAs 2979199114 @default.
- W2979199114 citedByCount "1" @default.
- W2979199114 countsByYear W29791991142012 @default.
- W2979199114 crossrefType "journal-article" @default.
- W2979199114 hasAuthorship W2979199114A5011659892 @default.
- W2979199114 hasAuthorship W2979199114A5025261212 @default.
- W2979199114 hasAuthorship W2979199114A5066575140 @default.
- W2979199114 hasAuthorship W2979199114A5086844845 @default.
- W2979199114 hasConcept C112705442 @default.
- W2979199114 hasConcept C11824378 @default.
- W2979199114 hasConcept C126322002 @default.
- W2979199114 hasConcept C142462285 @default.
- W2979199114 hasConcept C159047783 @default.
- W2979199114 hasConcept C2522874641 @default.
- W2979199114 hasConcept C2776408679 @default.
- W2979199114 hasConcept C2778159067 @default.
- W2979199114 hasConcept C2778767360 @default.
- W2979199114 hasConcept C2779182219 @default.
- W2979199114 hasConcept C2779298103 @default.
- W2979199114 hasConcept C2780040827 @default.
- W2979199114 hasConcept C2993143319 @default.
- W2979199114 hasConcept C526171541 @default.
- W2979199114 hasConcept C62231903 @default.
- W2979199114 hasConcept C71924100 @default.
- W2979199114 hasConcept C97320921 @default.
- W2979199114 hasConcept C98274493 @default.
- W2979199114 hasConceptScore W2979199114C112705442 @default.
- W2979199114 hasConceptScore W2979199114C11824378 @default.
- W2979199114 hasConceptScore W2979199114C126322002 @default.
- W2979199114 hasConceptScore W2979199114C142462285 @default.
- W2979199114 hasConceptScore W2979199114C159047783 @default.
- W2979199114 hasConceptScore W2979199114C2522874641 @default.
- W2979199114 hasConceptScore W2979199114C2776408679 @default.
- W2979199114 hasConceptScore W2979199114C2778159067 @default.
- W2979199114 hasConceptScore W2979199114C2778767360 @default.
- W2979199114 hasConceptScore W2979199114C2779182219 @default.
- W2979199114 hasConceptScore W2979199114C2779298103 @default.
- W2979199114 hasConceptScore W2979199114C2780040827 @default.
- W2979199114 hasConceptScore W2979199114C2993143319 @default.
- W2979199114 hasConceptScore W2979199114C526171541 @default.
- W2979199114 hasConceptScore W2979199114C62231903 @default.
- W2979199114 hasConceptScore W2979199114C71924100 @default.
- W2979199114 hasConceptScore W2979199114C97320921 @default.
- W2979199114 hasConceptScore W2979199114C98274493 @default.
- W2979199114 hasLocation W29791991141 @default.
- W2979199114 hasOpenAccess W2979199114 @default.
- W2979199114 hasPrimaryLocation W29791991141 @default.
- W2979199114 hasRelatedWork W1227234993 @default.
- W2979199114 hasRelatedWork W1969620637 @default.
- W2979199114 hasRelatedWork W2022544796 @default.
- W2979199114 hasRelatedWork W2109818488 @default.
- W2979199114 hasRelatedWork W2141202240 @default.
- W2979199114 hasRelatedWork W2157262647 @default.
- W2979199114 hasRelatedWork W2408963803 @default.
- W2979199114 hasRelatedWork W2621100040 @default.
- W2979199114 hasRelatedWork W2883591825 @default.
- W2979199114 hasRelatedWork W2883678106 @default.
- W2979199114 hasVolume "106" @default.
- W2979199114 isParatext "false" @default.
- W2979199114 isRetracted "false" @default.
- W2979199114 magId "2979199114" @default.
- W2979199114 workType "article" @default.